Company news
CRISPR Therapeutics AG news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Oral Presentation at the 25th European Hematology Association (EHA) Congress
May 13, 2020
CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001™ for the Treatment of Severe Hemoglobinopathies
May 10, 2020
CRISPR Therapeutics to Present at the Bank of America Securities 2020 Health Care Conference
May 6, 2020
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
April 27, 2020
CRISPR Therapeutics Proposes Changes to the Board of Directors
February 25, 2020
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
February 11, 2020
CRISPR Therapeutics to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top Conference
January 5, 2020
CRISPR Therapeutics to Present at Upcoming Investor Conferences
November 26, 2019
CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
November 18, 2019
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001® for Severe Hemoglobinopathies
November 18, 2019
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results
October 27, 2019
CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology
October 14, 2019
CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019
September 16, 2019
CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Beta Thalassemia
April 15, 2019
Decks
The 5 newest of 14 decks. Every deck is listed under its year.
- Q3 2026 Earnings Presentation
Earnings · 43 slides · Aug 3, 2026
- Corporate Update (February 2026)
Corporate update · 43 slides · Feb 12, 2026
- Corporate Update (2025)
Corporate update · 33 slides · Aug 24, 2025
- Investor Presentation (July 2025)
Investor deck · 33 slides · July 2025
- Corporate Update (2024)
Corporate update · 26 slides · Nov 17, 2024